Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The Imperial Cancer Research Fund—Cancer research for the future

Nature Medicine volume 4, pages 1224–1227 (1998)Cite this article

Abstract

Paul Nurse, winner of the 1998 Albert Lasker Basic Medical Research Award for his work on the cell cycle, began working at the Imperial Cancer Research Fund (ICRF) as Head of the Cell Cycle Control laboratory in 1984. Twelve years later he was appointed Director General of the ICRF and now describes the origins, structure and goal of the UK's largest cancer charity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Author information

Authors and Affiliations

  1. Director General Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London, WC2A 3PX, UK

    Paul Nurse

Authors
  1. Paul Nurse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nurse, P. The Imperial Cancer Research Fund—Cancer research for the future . Nat Med 4, 1224–1227 (1998). https://doi.org/10.1038/3202

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/3202

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing